Intercept's drug could do billions a year: Analyst

Now watching

Next video starts in : 7 Play

Intercept's drug could do billions a year: Analyst

Intercept's drug could do billions a year: Analyst
Replay video
Up next

Reading Japan's February industrial production

Unlock your personal NFL Now stream by signing in to NFL.com

Intercept's drug could do billions a year: Analyst

by CNBC Videos 2:08 mins

Shares of Intercept Pharmaceuticals are up more than 560 percent this week alone. Akiva Felt, Oppenheimer senior analyst, shares his optimistic view for the company.

View Comments (0)